Foot-and-mouth disease: A new antiviral stops the super-spreader in its tracks

Tatsuya Nishi and Kazuki Morioka tested the effectiveness of antiviral drug T-1105 against foot-and-mouth disease virus (FMDV) in pigs.

Dr Tatsuya Nishi and Dr Kazuki Morioka from the National Institute of Animal Health at the National Agriculture and Food Research Organization, Japan, have been testing a promising treatment against foot-and-mouth disease virus (FMDV). Feeding pigs an antiviral drug (T-1105) may prevent any outbreak from spreading since it inhibits pigs from producing virus particles. Pigs are currently thought to be […]

Read More… from Foot-and-mouth disease: A new antiviral stops the super-spreader in its tracks

Is monoclonal antibody therapy effective and achievable in hospitals with limited resources?

Dr Nikhitha Mantri researched the use of MAT treatments for COVID-19 patients with mild to moderate symptoms at an inner-city hospital with limited resources in the Bronx

Monoclonal antibody therapy (MAT) is a way of treating COVID-19 for people who have tested positive, have mild to moderate symptoms, and are at high risk of developing more serious symptoms and complications. Although there are already studies showing promising results, the number of patients in the US, especially ethnic minorities, who have so far received MAT is small. Dr […]

Read More… from Is monoclonal antibody therapy effective and achievable in hospitals with limited resources?